The metabolization of nanoparticles largely depends on their composition and surface characteristics. Some nanoparticles may undergo biotransformation in the liver, where they are broken down into smaller, possibly less toxic components. However, certain nanoparticles may resist biodegradation, leading to prolonged retention in the body.
